2021-06-28-世界卫生组织-Hypertension_Grenada_2020_country_profile_2页_380kb

报告摘要

In 2010, 39% of Grenada's adult population (approximately 19.7 thousand out of 106,227 people, or 19.7 thousand, as of 2010 estimates) had hypertension.
Approximately 11,000 individuals were aware of their condition (diagnosed).
About 2.9 thousand were under treatment.
Only 0.8 thousand (or approximately 7.3% of those with hypertension) had their blood pressure controlled.
Key risk factors include high sodium intake, physical inactivity, and poor dietary habits.

In 2019, Grenada had policies to reduce salt/sodium consumption that were "generally available."
Essential hypertension-related medicines (thiazide diuretics, ACE inhibitors, ARBs, calcium channel blockers, and beta-blockers) were reported as available in primary health care facilities.

Address modifiable risk factors through initiatives like MPOWER, ACTIVE, SHAKE, REPLACE, and HEARTS to reduce hypertension prevalence and improve control.
Focus on population-wide interventions, such as improving blood pressure measurement and treatment protocols.
Track hypertension prevalence and control rates through surveillance systems.

Uncontrolled hypertension prevalence in adults aged 18+ decreased over time, from 2000 to 2025 projections.
Age-specific data from 2010 shows higher awareness but lower control rates in younger age groups compared to older adults.
Definitions include hypertension based on blood pressure readings or doctor diagnosis, awareness if diagnosed and treated, and control if blood pressure is managed below threshold.

Data on prevalence and cascade derived from Grenada's 2010 STEPS survey and UN population estimates.
National County Capacity Survey for NCDs (2019) provided system response data.
WHO supports included through the Global Hearts Initiative.
No national-specific targets mentioned beyond the chronic NCD policy plan (2013-2017).

展开完整摘要

试读结束，高清完整版pdf/doc/ppt,请点下载